Neoplasia/BPH

	Multimodal CT radiomics and 2.5D deep learning for preoperative grading of clear cell renal cell carcinoma in older patients: a multicenter study. Front Oncol Wang Z, Liang Z, Lv D, Hu S, Zhou H, Li J, Bian X, Gao J, Zhao T, Gong B, Qiao Y, Shuang W. PMID: 43031732 [PubMed - as supplied by publisher]
	Hypoxia-inducible factor 2Î± inhibition in renal cell carcinoma: From von Hippel-Lindau biology to targeted therapeutics. Cancer Chen YW, Sano F, McKay RR. PMID: 43031368 [PubMed - in process]
	Integration of individual-level social determinants of health and associations with cardiovascular risk factors in breast and prostate cancer. Cancer Jung W, Hettinger G, Narayan V, Mei L, Takvorian S, Martei YM, Clark A, Huang A, Mcdermott K, Smith AM, Xia C, Ko K, Pagan JS, Koropeckyj-Cox D, Getz K, Guerra CE, Fayanju OM, Kumar S, Beyer KMM, Powell-Wiley T, Yancy C, Park YM, Ky B. PMID: 43031355 [PubMed - indexed for MEDLINE]
	Phospho-LATS1/2 Immunoreactivity and Survival in Muscle-Invasive Bladder Cancer: A Quantitative Immunohistochemical Study. Int J Urol Kakita S, Matsuo T, Otsubo A, Araki K, Honda H, Mori S, Mitsunari K, Ohba K, Imamura R. PMID: 43031265 [PubMed - indexed for MEDLINE]
	Impact of a Reminder App on Bladder Filling During Moderately Hypo-Fractionated Radiotherapy for Prostate Cancer: Results of the REFILL-PAC-HYPO Trial. J Clin Med Rades D, Janssen S, Doehring L, Küter JD, Staden MV, Al-Salool A, Koeck J, Domschikowski J, Schulz CF, Cacicedo J, Vestergård Madsen C, Kristiansen C. PMID: 43030701 [PubMed]
	From Radical Treatment to Structured Active Surveillance: A Narrative Review of Low-Risk Localized Prostate Cancer. J Clin Med Rodríguez-Parras P, Román-Ramos P, Zambudio-Munuera A, Arrabal-Polo MÁ. PMID: 43030434 [PubMed]
	Clinical Risk Models, Inflammatory-Nutritional Indices and a Neural-Network Survival Model in Metastatic Renal Cell Carcinoma: A Single-Center Retrospective Study. J Clin Med Sali M, Yigit E, Ard, Sali S, Coskun A, Ozcelik EE, Özmarasal, Akta, Sahin AB, Çubukçu E, Evrensel T, Deligönül A. PMID: 43030405 [PubMed]
	Pre-Diagnosis Metabolic Health-Related Dietary Index and Prostate Cancer-Specific Mortality. Nutrients Msibi SS, Woldehawariat K, Trinh N, Lee M, Su LJ. PMID: 43030330 [PubMed - indexed for MEDLINE]
	PSA Dynamics, Bounce, and Biochemical Recurrence Definitions After Low-Dose-Rate Brachytherapy for Prostate Cancer: A Narrative Review with Cross-Modality Comparison. Diagnostics (Basel) Kahchiev N, Popov E, Vasileva V, Dimitrov G. PMID: 43028560 [PubMed]
	Contrast-Enhanced Ultrasound Combined with the NLR-PMR Phenotype for Prostate Cancer Prediction and Risk Stratification in Patients with PSA 4-20 ng/mL and PI-RADS â‰¤ 3. Diagnostics (Basel) Zhou W, Ding Z, Guo Y, Han J, Zhao H, Bai X, Cheng W, Wu B. PMID: 43028552 [PubMed]
	Transcriptional Reprogramming in Prostate Cancer: Altered AR Activity, the Modulatory Role of CDK8/19, and Prospects for Combination Therapy. Int J Mol Sci Dodina M, Pavlova P, Kuzkokova P, Krasnyi A, Shtil A, Ivanov R, Minskaia E. PMID: 43028101 [PubMed - indexed for MEDLINE]
	Immune-Related Proteomic Profiling in Clear Cell Renal Cell Carcinoma: Tissue and Soluble Biofluid Biomarkers. Int J Mol Sci Anatoliotaki C, Antonouli S, Tzortzis V, Vlachostergios PJ, Zachos I, Thodou E, Giakountis A, Samara M. PMID: 43028010 [PubMed - indexed for MEDLINE]
	Clinical Utility of lncRNAs in Urothelial Carcinoma of the Bladder: Diagnostics, Risk Stratification, and Treatment Guidance. Int J Mol Sci , Franczyk B, Sagr A, Popek K, Tabarkiewicz J. PMID: 43027714 [PubMed - indexed for MEDLINE]
	PTEN Deletion, mTORC1 Signatures and CAD Expression in Primary Prostate Cancer: Protein-Level Data and the Role of ERG Fusion. Cells Arora I, Rath S, Jamal QMS, Aljohani A, Hamid A, Abu-Zaid A, Khan MI, Yaqinuddin A. PMID: 43027353 [PubMed - indexed for MEDLINE]
	Mechanisms of Response and Resistance to Immune Checkpoint Inhibitors in Renal Cell Carcinoma. Cells Milella M, Lasorsa F, Rutigliano M, Caniglia A, Naglieri E, Pandolfo SD, Ditonno P, Lucarelli G. PMID: 43027312 [PubMed - indexed for MEDLINE]
	Stroma, Stress and Mitotic Control in Prostate Cancer: Evaluating Periostin, MAPK8IP2, CDCA3 and NCAPG2 Within an Evidence Gap Framework. Biology (Basel) Alonso-Aguirre V, Sánchez-Espinosa A, García-Rodríguez J, Lázaro-Sánchez AD, Luengo-Gil G. PMID: 43027037 [PubMed]
	Predictors of Benefit from Immune Checkpoint Inhibitors in Urothelial Carcinoma of the Bladder: The Limits of PD-L1 and the Rise of Circulating Tumor DNA-Guided Adjuvant Therapy. Cancers (Basel) Novacescu D, Musta M, Caprariu R, Dumitru CS, Barb AC, Armega-Anghelescu A, Dragomir R, Baloi A, Latcu S, Petrica FL, Cumpanas A, Zara F. PMID: 43026901 [PubMed]
	Revealing the Invisible: Circulating and Urinary Tumor DNA in Bladder Cancer. Cancers (Basel) Qin SL, Owusu-Amo B, Miyamoto DT. PMID: 43026888 [PubMed]
	Late Vertebral Metastasis in Long-Term Survivors of Breast, Prostate, and Renal Cell Cancer. Cancers (Basel) Berry-Candelario J. PMID: 43026864 [PubMed]
	ACP3 Theranostics in Prostate Cancer. Cancers (Basel) Luo Z, Chen D, Ma T, Zeng P, Li X, Shi H, Hu Z. PMID: 43026833 [PubMed]

Articles 1 - 20 / 192885

Page 1 of 9645



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy